Meteora Capital, LLC 13D and 13G filings for NKGen Biotech, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 12:29 pm Sale | 2025-03-31 | 13G | NKGEN BIOTECH INC NKGN | Meteora Capital, LLC | 2,755,935 6.130% | -16,210 (-0.58%) | Filing |
| 2025-02-14 10:34 am Purchase | 2024-12-31 | 13G | NKGEN BIOTECH INC NKGN | Meteora Capital, LLC | 2,772,145 7.840% | 2,772,145 (New Position) | Filing |
| 2024-05-10 2:42 pm Sale | 2024-05-10 | 13G | NKGEN BIOTECH INC NKGN | Meteora Capital, LLC | 0 0.000% | -1,596,817 (Position Closed) | Filing |
| 2024-02-14 1:05 pm Purchase | 2023-12-31 | 13G | NKGEN BIOTECH INC NKGN | Meteora Capital, LLC | 1,596,817 7.300% | 1,596,817 (New Position) | Filing |